X hits on this document

Word document

The usefulness and use of second-generation - page 27 / 81

211 views

0 shares

0 downloads

0 comments

27 / 81

Risperidone

Borison et al., 1992 [165]

RCT, double-blind; placebo and haloperidol comparators

Risperidone

Claus et al., 1992 [166]

RCT, double-blind; haloperidol comparator

Sertindole

Lewis et al., 2000 [167]

Meta-analysis

Ziprasidone

Daniel et al.,1997 [108]

RCT comparing 2 mg with 20 mg intramuscular ziprasidone

Ziprasidone

Lesem et al., 2001 [168]

RCT comparing 2 mg and 10 mg intramuscular ziprasidone

Ziprasidone

Brook et al., 2000 [169]

Open label comparison of ziprasidone intramuscular + PO and haloperidol intramuscular + PO

Ziprasidone

Bagnall et al., 2000 [170]

Meta-analysis

Zotepine

Cooper et al., 2000 [171]

RCT, double-blind; placebo-controlled

Zotepine

Cooper et al.,  2000 [172]

RCT, double-blind;

placebo, chlorpromazine comparators

Zotepine

Bagnall et al., 2000 [96]

Meta-analysis

Zotepine

Petit et al., 1996 [173]

RCT, double-blind;

haloperidol comparator

Zotepine

Barnas et al.,  1992 [174]

RCT, double-blind;

haloperidol comparator

Zotepine

Harada et al.,  1991 [175]

Open label

Zotepine

Klieser et al.,  1991 [176]

RCT, double-blind;

haloperidol comparator

Zotepine

Müller-Spahn et al.,  1991 [177]

RCT, double-blind;

perazine comparator

Zotepine

Wetzel et al., 1991 [178]

RCT, double-blind;

perazine comparator

Zotepine

Fleischhacker et al.,  1989 [179]

RCT, double-blind;

haloperidol-controlled

Zotepine

Fleischhacker et al.,  1987 [180]

Open label

Zotepine

Sarai and Okada,  1987 [181]

RCT, doube-blind;

thiothixene comparator

RCT, Randomized controlled trial;  PO, oral.

Document info
Document views211
Page views211
Page last viewedWed Dec 07 19:58:33 UTC 2016
Pages81
Paragraphs1517
Words24865

Comments